A contemporary approach to developing health policies: the Dubai Health Authority as a case study
Frontiers in Public Health · 01.07.2026 · 14
DOI: 10.3389/fpubh.2026.1864765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 01.07.2026. Verfasst von Nahed Monsef und 5 weiteren Autor:innen. Beteiligte Einrichtung: Strategy & Governance Department, Dubai Health Authority, Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Health Policy, Policy Making. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Health governance is shifting from reactive decision-making to proactive, evidence-informed policy processes. In Dubai, the Dubai Health Authority’s repositioning as a regulator and health-system steward created a need for a more systematic approach to health policy prioritization, development, and evaluation.
Context
Health policy development in Dubai was historically strategy-driven and top-down. Although this supported rapid sectoral growth, it also risked fragmented decision-making, limited cross-system coordination, and inconsistent assessment of policy impact. Drawing on evidence-informed policymaking and Kingdon’s multiple streams framework, the Strategy and Governance Department conceptualized policy development as the alignment of policy problems, technically feasible options, and political and stakeholder legitimacy. Programmatic elements The methodology uses the Adjusted Priority Index, a semi-quantitative MCDA-informed agenda-setting tool, to prioritize prospective policy research topics according to legal feasibility, strategic alignment, government directives, risk, opportunity, urgency, and expected impact. Prioritized topics are then proceeded through structured policy labs covering problem definition, policy framework development, stakeholder analysis, situational assessment, benchmarking, alternatives analysis, theory of change, implementation planning, and impact assessment. Policy champions, internal guidelines, and recurring workshops support methodological consistency and institutional capacity.
Discussion
Early outputs include a three-year health policy agenda, structured policy rationales, transparent prioritization records, stronger cross-departmental coordination, and improved methodological literacy among policy teams and stakeholders. These outputs indicate institutional uptake and implementation readiness, but not final policy effectiveness.
Conclusion
Dubai’s experience shows how evidence-informed policy methods can be adapted to a complex and rapidly evolving health system. Formal evaluation is needed to assess implementation quality, policy coherence, and longer-term contributions to health-system performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Strategy & Governance Department, Dubai Health Authority, Dubai, United Arab Emirates.
- Dubai Medical University, Dubai, United Arab Emirates.
- Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.
- University of Sharjah, Sharjah, United Arab Emirates.
Zitieren
APA
Monsef, N., Suliman, E., Elgeneadi, Y., Ashkar, E., AlMheiri, A., & Arjomand, S. M. (2026). A contemporary approach to developing health policies: the Dubai Health Authority as a case study. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1864765
Vancouver
Monsef N, Suliman E, Elgeneadi Y, Ashkar E, AlMheiri A, Arjomand SM. A contemporary approach to developing health policies: the Dubai Health Authority as a case study. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1864765
BibTeX
@article{Monsef2026,
author = {Monsef, Nahed and Suliman, Eldaw and Elgeneadi, Yamen and Ashkar, Elham and AlMheiri, Amna and Arjomand, Shahd Mohammad},
title = {A contemporary approach to developing health policies: the Dubai Health Authority as a case study},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1864765}
}
EUVIMED